Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

IE00BTN1Y115
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG000BNWG87
MDT
Medtronic PLC
GICS: Health Care · SECTOR: Healthcare · SUB-SECTOR: Medical - Devices · THEMEFOLIO: $HLTH
NAME
Medtronic PLC
ISIN
IE00BTN1Y115
TICKER
MDT
MIC
XNYS
REUTERS
MDT.N
BLOOMBERG
MDT US
Sat, 25.04.2026       Medtronic
IE00BTN1Y115

HRS late-breaking data: Interim results highlight six-month outcomes for patients treated with the Sphere-9 catheter for sustained monomorphic ventricular tachycardia (VT)Breakthrough device designation granted for use of the Sphere-9 catheter for treatment of VT; U.S. pivotal trial approved by FDANew at HRS: data show consistent durability for th...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Mon, 20.04.2026       Medtronic
IE00BTN1Y115

CathWorks FFRangio® System employs drug-free, wire-free technology for comprehensive physiological assessmentGALWAY, Ireland, April 20, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has completed its acquisition of CathWorks, a privately held medical device company, which aims to transf...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Mon, 13.04.2026       Medtronic
IE00BTN1Y115

GALWAY, Ireland, April 13, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Wednesday, June 3, 2026, for its fourth quarter and full fiscal year 2026, which ends on Friday, April 24, 2026.A news release containing summary financial information will be...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Fri, 27.03.2026       Medtronic
IE00BTN1Y115

GALWAY, Ireland, March 27, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth AXiS™ surgical system for cranial and ear, nose, and throat (ENT) procedures. Cleared for spine procedures in February, the Stealth AXiS™ surgical system u...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Thu, 26.03.2026       Medtronic
IE00BTN1Y115

Das Instrument 2M6 IE00BTN1Y115 MEDTRONIC PLC DL-,0001 EQUITY wird ex Dividende/Zinsen gehandelt am 27.03.2026 The instrument 2M6 IE00BTN1Y115 MEDTRONIC PLC DL-,0001 EQUITY has its ex-dividend/interest day on 27.03.2026...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Mon, 23.03.2026       Medtronic
IE00BTN1Y115

Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded indication for the OmniaSecure™ d...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Tue, 10.03.2026       Medtronic
IE00BTN1Y115

Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'GALWAY, Ireland, March 10, 2026 /PRNewswire/ -- Medtronic today announced its entry into a definitive agreement to acquire Scientia Vascular, a company with critical, innovative technology across the neurovascular portfolio. The acquisition i...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Fri, 06.03.2026       Medtronic
IE00BTN1Y115

GALWAY, Ireland, March 6, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that MiniMed Group, Inc. (Nasdaq: MMED) will begin trading today on the Nasdaq Global Select Market (Nasdaq) under the ticker symbol "MMED" in connection with its initial public offering ("IPO")."Today marks an exciting mil...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Fri, 06.03.2026       Medtronic
IE00BTN1Y115

GALWAY, Ireland and NORTHRIDGE, Calif., March 5, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a subsidiary of Medtronic plc (Medtronic) (NYSE: MDT), today announced the pricing of its initial public offering (IPO) of 28,000,000 shares of its common stock at a price to the public of $20.00 per share. The shares are expected to begin trading...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Fri, 06.03.2026       Medtronic
IE00BTN1Y115

GALWAY, Ireland and NORTHRIDGE, Calif., March 5, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a subsidiary of Medtronic plc (Medtronic) (NYSE: MDT), today announced the pricing of its initial public offering (IPO) of 28,000,000 shares of its common stock at a price to the public of $20.00 per share. The shares are expected to begin trading...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Thu, 05.03.2026       Medtronic
IE00BTN1Y115

GALWAY, Ireland, March 5, 2026 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, March 5, 2026, approved the company's cash dividend for the fourth quarter of fiscal year 2026 of $0.71 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2025....
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Tue, 03.03.2026       Medtronic
IE00BTN1Y115

GALWAY, Ireland, March 3, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that Thierry Piéton, Medtronic executive vice president and chief financial officer, will participate in fireside chats at the following investor conferences:Barclays 28th Annual Global Healthcare ConferenceTuesday, Ma...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Wed, 25.02.2026       Medtronic
IE00BTN1Y115

Real-time actionable insights on one mobile app for people who manage their diabetes using multiple daily injectionsGALWAY, Ireland, Feb. 25, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the commercial launch in Europe of the MiniMed Go™ Smart MDI system with the Simplera™ sensor. The system...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Tue, 24.02.2026       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Feb. 24, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a subsidiary of Medtronic plc (Medtronic) (NYSE: MDT), today announced that it has launched a roadshow for the initial public offering (IPO) of 28,000,000 shares of its common stock. The proposed offering is part of Medtronic's previously announced plan to separate its D...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Tue, 17.02.2026       Medtronic
IE00BTN1Y115

Cardiovascular portfolio up 11% year-over-year; Cardiac Ablation Solutions grew 80% on strength of pulsed field ablation portfolioGALWAY, Ireland, Feb. 17, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its third quarter (Q3) of fiscal year 2026 (FY26), which ended Ja...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Tue, 17.02.2026       Medtronic
IE00BTN1Y115

Cardiovascular portfolio up 11% year-over-year; Cardiac Ablation Solutions grew 80% on strength of pulsed field ablation portfolioGALWAY, Ireland, Feb. 17, 2026 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its third quarter (Q3) of fiscal year 2026 (FY26), which ended January 2...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Tue, 17.02.2026       Medtronic
IE00BTN1Y115

Newly FDA-cleared system helps expand patient access to minimally invasive surgeryCleveland Clinic joins nationally recognized academic medical centers including Atrium Health Wake Forest Baptist High Point Medical Center as first hospitals in the U.S. to install Hugo RAS systemGALWAY, Ireland, Feb. 17, 2026 /PRNewswire/ -- Medtronic today announc...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Fri, 13.02.2026       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Feb. 13, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth AXiS™ surgical system, a next-generation platform that brings planning, navigation, and robotics together into a single, intelligent system for spine surger...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Wed, 11.02.2026       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Feb. 11, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, February 17, 2026, for its third quarter of fiscal year 2026, which ended on Friday, January 23, 2026.A news release containing summary financial information will be i...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Tue, 03.02.2026       Medtronic
IE00BTN1Y115

Deal demonstrates Medtronic's commitment to expanding pipeline through strategic investments and targeted acquisitions Exercising option to acquire will bolster Medtronic's interventional cardiology portfolio, expanding its leadership in transforming how cardiovascular disease is diagnosed and treatedMedtronic's intent to acquire follows a 2022 st...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Mon, 02.02.2026       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Feb. 2, 2026  /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice, and flexibility for people living with type 1 and insulin‑requiring type 2 diabetes. These milestones include Medicare access for the MiniMed™ 780G system pair...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Fri, 23.01.2026       Medtronic
IE00BTN1Y115

First-of-its-kind, rotation-free single-shot PFA catheter supported by strong safety and efficacy data adds to the groundbreaking Affera family of technologies in EuropeSuccessful completion of first cases at multiple sites kicks off Horizon 360 IDE pivotal trial in the United StatesGALWAY, Ireland, Jan. 23, 2026 /PRNewswire/ -- Medtronic plc (NYS...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Mon, 12.01.2026       Medtronic
IE00BTN1Y115

MiniMed Go™ is the first and only smart MDI system that automatically integrates insulin dosing and glucose data in a single app to provide empowering insights for individuals on multiple daily injectionsGALWAY, Ireland, Jan. 12, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Dru...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Wed, 07.01.2026       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Jan. 7, 2026 /PRNewswire/ -- A new real-world retrospective analysis published in Diabetes Care showed that users of the MiniMed™ 780G system achieved American Diabetes Association (ADA) recommended goals for time-in-range (TIR)— even on days when mealtime boluses were missed. CareLink™ data showed that the studied user population...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Mon, 05.01.2026       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Jan. 5, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual J.P. Morgan healthcare conference on Monday, January 12, 2026.Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation and answer questions on...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Wed, 24.12.2025       Medtronic
IE00BTN1Y115

Das Instrument 2M6 IE00BTN1Y115 MEDTRONIC PLC DL-,0001 EQUITY wird cum Dividende/Zinsen gehandelt am 24.12.2025 und ex Dividende/Zinsen am 29.12.2025 The instrument 2M6 IE00BTN1Y115 MEDTRONIC PLC DL-,0001 EQUITY has its pre-dividend/interest day on 24.12.2025 and its ex-dividend/interest day on 29.12.2025...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Fri, 19.12.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Dec. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Diabetes business, which as previously announced will operate under the name MiniMed, has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) for a proposed initi...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Thu, 04.12.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Dec. 4, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 4, 2025, approved the company's cash dividend for the third quarter of fiscal year 2026 of $0.71 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2025...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Wed, 03.12.2025       Medtronic
IE00BTN1Y115

Hugo RAS system brings choice to the U.S., coupled with the full suite of Medtronic surgical offerings, ultimately creating a connected and integrated operating room today and into the future.GALWAY, Ireland, Dec. 3, 2025 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in surgical innovation, today announced the U.S. Food and Drug Administr...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Tue, 02.12.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Dec. 2, 2025  /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated with the Instinct sensor, made by Abbott and designed exclusively for MiniMed™ systems. Following U.S. FDA clearance of the system earlier this year...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Tue, 18.11.2025       Medtronic
IE00BTN1Y115

Cardiac Ablation Solutions growth of 71% on strength of pulsed field ablation (PFA) portfolio; Raising FY26 revenue and EPS guidance GALWAY, Ireland, Nov. 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announc...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Tue, 18.11.2025       Medtronic
IE00BTN1Y115

Cardiac Ablation Solutions growth of 71% on strength of pulsed field ablation (PFA) portfolio; Raising FY26 revenue and EPS guidance GALWAY, Ireland, Nov. 18, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced fina...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Wed, 05.11.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Nov. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, November 18, 2025, for its second quarter of fiscal year 2026, which ended on Friday, October 24, 2025....
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Tue, 28.10.2025       Medtronic
IE00BTN1Y115

Symplicity blood pressure procedure is now covered for qualifying Medicare patients GALWAY, Ireland, Oct. 28, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Centers for Medicare & Medicaid Services (CMS) has released the final...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Sun, 26.10.2025       Medtronic
IE00BTN1Y115

Long-term data shows significant and sustained blood pressure reductions in both office-based and 24-hour ambulatory blood pressure, reinforcing the durability, safety and effectiveness of the Symplicity™ blood pressure procedure in patients prescribed antihypertensive medications...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Thu, 09.10.2025       Medtronic
IE00BTN1Y115

TIME Best Inventions honors extraordinary innovations changing lives DUBLIN, Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that BrainSense™ Adaptive Deep Brain Stimulation (aDBS) – the world's...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Wed, 08.10.2025       Medtronic
IE00BTN1Y115

First procedures completed and enrollment underway in Embrace Gynecology study, furthering the company's progress to expand minimally invasive treatment options to patients in the United States GALWAY, Ireland, Oct. 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced the start of the...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Mon, 29.09.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Sept. 29, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public offering (the "Offering") of €750,000,000 principal amount of 2.950% senior notes due 2030 and €750,000,000 principal...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Thu, 25.09.2025       Medtronic
IE00BTN1Y115

Das Instrument 2M6 IE00BTN1Y115 MEDTRONIC PLC DL-,0001 EQUITY wird ex Dividende/Zinsen gehandelt am 26.09.2025 The instrument 2M6 IE00BTN1Y115 MEDTRONIC PLC DL-,0001 EQUITY has its ex-dividend/interest day on 26.09.2025...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Fri, 19.09.2025       Medtronic
IE00BTN1Y115

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland, Sept. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced today that it has received U.S. Food and Drug Administration (FD...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Mon, 15.09.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Sept. 15, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Offering") of €750,000,000 principal amount of 2.950% senior notes due 2030 and €750,000,000 principal amount of 4.200% senior notes due 2045 (collective...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Mon, 15.09.2025       Medtronic
IE00BTN1Y115

Study to evaluate whether a new approach to pacing the heart can improve the lives of patients with heart failure with preserved ejection fraction (HFpEF) who have limited treatment options today GALWAY, Ireland, Sept. 15, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the initiation of a...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Thu, 04.09.2025       Medtronic
IE00BTN1Y115

First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting GALWAY, Ireland and NASHVILLE, Tenn., Sept. 4, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced results from the Enable Hernia Repair clinical study evaluating the performa...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Tue, 02.09.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden the MiniMed™ 780G system portfolio: clearance of the SmartGuard™ algorithm as an interoperable automated glycemic controller (iAGC), enab...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Fri, 29.08.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Aug. 29, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences: 2025 Wells Fargo Healthcare Conference Thursday, September 4, 2025, at 8:00 a.m. EDT (7:00 a.m. CDT)Geoff Martha, Medtronic chairman and chief executive offic...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Fri, 29.08.2025       Medtronic
IE00BTN1Y115

GALWAY, Ireland, Aug. 29, 2025 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences: 2025 Wells Fargo Healthcare Conference Thursday, September 4, 2025, at 8:00 a.m. EDT (7:00 a.m. CDT)Geoff Martha, Medtronic chairman and chief executive officer, and...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Tue, 19.08.2025       Medtronic
IE00BTN1Y115

Experienced executives John Groetelaars and Bill Jellison appointed to the Board of Directors Board forms new Growth and Operating committees to sharpen focus on the company's ongoing strategic portfolio management, operational execution and capital allocation Plan to host Investor Day in 2026 Initiatives follow constructive engagement with Ellio...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Tue, 19.08.2025       Medtronic
IE00BTN1Y115

Experienced executives John Groetelaars and Bill Jellison appointed to the Board of Directors Board forms new Growth and Operating committees to sharpen focus on the company's ongoing strategic portfolio management, operational execution and capital allocation Plan to host Investor Day in 2026 Initiatives follow constructive engagement with Ellio...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Tue, 19.08.2025       Medtronic
IE00BTN1Y115

11th quarter in a row of mid-single digit organic revenue growth;Poised to accelerate growth GALWAY, Ireland, Aug. 19, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its first quarter (Q1) of fiscal year 2026 (FY26), which ended July 25, 2025....
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink
Tue, 19.08.2025       Medtronic
IE00BTN1Y115

11th quarter in a row of mid-single digit organic revenue growth; Poised to accelerate growth GALWAY, Ireland, Aug. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its first quarter (Q1) of fiscal year 2026 (FY26), which ended July 25, 2025. Key Highlights...
Read more
Medtronic
Technical Analysis Termsheets Terminal
Permalink